Sat, Apr 27, 2024
[Archive]
Volume 4, Issue 1 (Feb 2019)
JNFS 2019, 4(1): 58-65 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Panjeshahin A, Khosravi M, Hosseinzadeh M. Polycystic Ovary Syndrome and Dietary Patterns in Iran: A Review Study. JNFS 2019; 4 (1) :58-65
URL: http://jnfs.ssu.ac.ir/article-1-238-en.html
URL: http://jnfs.ssu.ac.ir/article-1-238-en.html
Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd.
Abstract: (3397 Views)
Background: Polycystic Ovary Syndrome (PCOs) is one of the most common metabolic and endocrine abnormalities among women in reproductive age. In the case of not comprehensive treatment, PCOs can lead to hormonal, metabolic, and fertility disorders. The exact cause of PCOs is still unclear. This disease seems to have a genetic background caused by the interference of several key genes with the environmental factors such as dietary habit and food intake, which play an important role in prevention and treatment of this syndrome. Methods: We searched Scopus, PubMed, SID, and Magiran data bases to find the studies conducted in Iran on dietary patterns, dietary intake, food intake, and PCOs published in English. Results: The findings showed that decrease of weight and fat intake from total calorie (especially saturated fat and cholesterol), increase of physical activity and intake of dietary fibers can improve this syndrome. Furthermore, DASH diet, increase of the protein/carbohydrate ratio in the diet, the low-calorie diets, or iso-caloric diets with a low glycemic index can also be useful in this regard. Discussion: In recent studies, the effects of some healthy diets were studied on PCOs women. A few of these studies were about finding appropriate dietary patterns for PCOs patients, but their number was limited. So, further studies are needed in this regard.
Type of article: review article |
Subject:
public specific
Received: 2018/04/22 | Published: 2019/02/1 | ePublished: 2019/02/1
Received: 2018/04/22 | Published: 2019/02/1 | ePublished: 2019/02/1
References
1. Ahmadi A, et al. 2013. Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian journal of endocrinology and metabolism. 17 (4): 672-676.
2. Amr N & Abdel-Rahim HE 2015. The effect of chromium supplementation on polycystic ovary syndrome in adolescents. Journal of pediatric and adolescent gynecology. 28 (2): 114-118.
3. Asemi Z & Esmaillzadeh A 2015. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Hormone and metabolic research. 47 (3): 232-238.
4. Asemi Z, et al. 2014. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: A randomized clinical trial. Nutrition. 30 (11-12): 1287-1293.
5. Asemi Z, Tabassi Z, Samimi M, Fahiminejad T & Esmaillzadeh A 2013. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. British journal of nutrition. 109 (11): 2024-2030.
6. Azadbakht L, et al. 2011. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes care. 34 (1): 55-57.
7. Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H & Nadjarzadeh A 2017. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. Journal of human nutrition and dietetics. 30 (3): 275-283.
8. Carmina E, Guastella E & Longo RA 2016. Advances in the diagnosis and treatment of PCOs. Current pharmaceutical design. 22 (36): 5508-5514.
9. Chen X, Touyz RM, Park JB & Schiffrin EL 2001. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 38 (3): 606-611.
10. Cree-Green M 2017. Worldwide Dissatisfaction With the Diagnostic Process and Initial Treatment of PCOS. Journal of clinical endocrinology & metabolism. 102 (2): 375-378.
11. Ehsani B, et al. 2016. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Clinical nutrition. 35 (5): 1181-1187.
12. Faghfoori Z, Fazelian S, Shadnoush M & Goodarzi R 2017. Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes & metabolic syndrome. 11: S429-432.
13. Farshchi H, Rane A, Love A & Kennedy RL 2007. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management. Journal of obstetrics and gynaecology 27 (8): 762-773.
14. Foroozanfard F, et al. 2017. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Mullerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clinical endocrinology. 87 (1): 51-58.
15. Goodarzi MO, Dumesic DA, Chazenbalk G & Azziz R 2011. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology. 7 (4): 219-231.
16. Jalilian A, et al. 2015. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. Iranian journal of reproductive medicine. 13 (10): 591-604.
17. Kalem MN, Kalem Z & Gurgan T 2017. Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles. Journal of endocrinological investigation. 40 (7): 745-752.
18. Love JG, et al. 2016. The experiences of women with polycystic ovary syndrome on a very low-calorie diet. Internationa journal womens health. 8: 299-310.
19. Luo X & Xu L 2012. Association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome. Journal of southern medical University. 32 (9): 1325-1327.
20. Onakpoya IJ, Perry R, Zhang J & Ernst E 2011. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials. Nutrition reviews. 69 (6): 335-343.
21. Palomba S, Santagni S, Falbo A & La Sala GB 2015. Complications and challenges associated with polycystic ovary syndrome: current perspectives. International journal womens health. 7: 745-763.
22. Pastore LM, Patrie JT, Morris WL, Dalal P & Bray MJ 2011. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. Journal of psychosomatic research. 71 (4): 270-276.
23. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HHM & Martínez JA 2010. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 26 (5): 534-541.
24. Razavi Zade M, et al. 2016. The effects of DASH diet on weight loss and metabolic status in adults with non‐alcoholic fatty liver disease: a randomized clinical trial. Liver international. 36 (4): 563-571.
25. Shishehgar F, et al. 2016. Comparison of dietary intake between polycystic ovary syndrome women and controls. Global journal of health science. 8 (9): 54801.
26. Soltani S, Shirani F, Chitsazi MJ & Salehi‐Abargouei A 2016. The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled clinical trials. Obesity reviews. 17 (5): 442-454.
27. Sorensen LB, Soe M, Halkier KH, Stigsby B & Astrup A 2012. Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome. American journal clinical nutrition. 95 (1): 39-48.
28. Vollmer WM, et al. 2001. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Annals of internal medicine. 135 (12): 1019-1028.
29. Wang ET, et al. 2011. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstetrics & gynecology. 117 (1): 6-13.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
